SOUTHERN FINANCIAL 1-LC ACCT.
For the Period 8/1/I3 to sam3
Note '• Unrealized Gairt Loss is shown as NA" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan team for additional
information.
Equity Detail
Adjusted Cost Unrealized Est. Annual Inc.
Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield
US Large Cap Equity
ARIAD PHARMACEUTICALS INC 18.60 16,535.000 307,551.00 290,997.40 16,553.60
04033A-10-0 ARIA
BIOGEN IDEC INC 213.02 2,095.000 446,276.90 250,454.95 195,821.95
09062X-10-3 BilB
FACEBOOK INCA 41.29 17,500.000 722,645.00 665,000.00 57,645.00
30303M-10-2 FB
GENERAL ELECTRIC CO 23.14 23,000.000 532,220.00 498,109.08 36,110.92 17,480.00 3.28%
369604-10-3 GE
JPM VALUE ADVANTAGE FD -1NSTL 24.98 78,709.170 1,984,580.88 2,000,000.00 (35,419.12) 19,992.12 1.02%
FUND 1400
4812A2-58-7 JVAI X
Total US Large Cap Equity $3,973,273.78 $3,702,581.43 $270,712.35 $37.472.12 0.94%
US Small/Mid Cap Equity
DEUTSCHE BK AG LDN BRH 8.90 50,000 000 445.c00 00 352,529.00 92 471 03
DBL LONG ETN38
25154H-55-8 DAG
J.P. Morgan Account Page 5 o' 48 Consolidated Statement Page 8
Confidential Treatment Requested by JPMorgan JPM-SDNY-00023382
Chase
CONFIDENTIAL SDNY_GM_00292580
EFTA01499594